Benzhydrocodone

Summary

Benzhydrocodone (CHEMBL3137321) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 403.5 Da · C25H25NO4

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL3137321
Name	Benzhydrocodone
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	76314940
Molecular formula	C25H25NO4
Molecular weight	403.5
InChIKey	VPMRSLWWUXNYRY-NDOYXKHWSA-N

SMILES: CN1CC[C@]23[C@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=CC4)OC(=O)C6=CC=CC=C6

IUPAC name: [(4R,4aS,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] benzoate

Also known as: Benzhidrocodona, Benzhydrocodone, KP-201 FREE BASE, KP201 FREE BASE, BENZHYDROCODONE

Parent form; salt/anhydrous children: CHEMBL3137310

Patent coverage: 10 distinct patent families (20 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).